Jardiance Pricing and Medicare Coverage in 2026

Jardiance, the brand name for empagliflozin, is an oral prescription medication used to treat type 2 diabetes, reduce cardiovascular risk, and manage heart failure. As drug pricing policies evolve under Medicare, particularly in 2026, beneficiaries need a clear picture of what costs to anticipate and how coverage works across different plan types.

This article is for informational purposes only and should not be considered medical advice. Please consult a qualified healthcare professional for personalized guidance and treatment.

What Drives Jardiance Prices?

Jardiance is a brand-name medication manufactured by Boehringer Ingelheim and Eli Lilly. Because no generic version is widely available in the United States, the list price remains high. As of the most recent data available, the retail cost for a 30-day supply can range from approximately $550 to over $600 without insurance. Several factors influence this price, including manufacturer pricing decisions, pharmacy benefit manager negotiations, and whether a patient has insurance or a discount program. The Inflation Reduction Act has introduced measures that may affect how Medicare negotiates certain drug prices, and Jardiance could be subject to these changes in coming years.

Medicare Considerations for 2026

Medicare Part D is the primary route through which beneficiaries access prescription drug coverage, including for Jardiance. In 2026, notable changes to Part D take effect as a result of the Inflation Reduction Act. One of the most significant updates is the $2,000 annual out-of-pocket cap for Medicare Part D enrollees. Once a beneficiary reaches this threshold, they pay nothing more for covered drugs for the rest of the plan year. This change is particularly relevant for those taking expensive brand-name medications like Jardiance, as it provides a ceiling on annual spending. Additionally, the Medicare Prescription Payment Plan allows beneficiaries to spread out-of-pocket costs evenly across monthly payments throughout the year.

Coverage and How Plans Vary

Not all Medicare Part D plans cover Jardiance in the same way. Coverage depends on a plan’s formulary, which is the list of covered drugs and their assigned tiers. Jardiance is typically placed on a higher formulary tier, meaning cost-sharing is greater than for generic medications. Some Medicare Advantage plans that include Part D drug coverage may negotiate different terms with manufacturers, potentially affecting what you pay. It is important to review your specific plan’s formulary each year during the annual open enrollment period, which runs from October 15 to December 7, to confirm whether Jardiance is covered and at what tier.

How Pricing Affects Beneficiaries

For beneficiaries on fixed incomes, the cost of Jardiance can be a significant monthly expense before the out-of-pocket cap is reached. Under the 2026 Part D structure, the catastrophic coverage phase has been restructured so that beneficiaries are better protected earlier in the year. However, the initial deductible and copay phases can still result in substantial costs in the first months of a plan year. Individuals with limited income and resources may qualify for the Extra Help program, also known as the Low Income Subsidy, which reduces premiums, deductibles, and copays for Part D plans. Boehringer Ingelheim also offers a patient assistance program for eligible individuals who do not have adequate insurance coverage.

Prices, rates, or cost estimates mentioned in this article are based on the latest available information but may change over time. Independent research is advised before making financial decisions.

Copays and What to Expect at the Pharmacy

Copays for Jardiance under Medicare Part D vary based on the plan, the drug tier, and where you are in your benefit phases. In the deductible phase, you may pay the full negotiated cost until your deductible is met. In the initial coverage phase, you pay a copay or coinsurance percentage. Under the 2026 reforms, the coverage gap, sometimes called the donut hole, has been effectively eliminated for most beneficiaries. Once you have spent $2,000 out of pocket in a calendar year, your copays drop to zero for the rest of the year. Keeping records of your spending and checking your plan’s Explanation of Benefits can help you track where you stand at any point during the year.

Navigating Jardiance costs under Medicare in 2026 requires attention to plan formularies, awareness of new Part D rules, and knowledge of available assistance programs. With the right information, beneficiaries can make more informed decisions about their prescription coverage and minimize unexpected financial strain.